Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Nigeria aims to get 42 mln COVID-19 vaccines through COVAX scheme

Published 05/01/2021, 20:29
Updated 05/01/2021, 20:30
© Reuters

By Felix Onuah
ABUJA, Jan 5 (Reuters) - Nigeria hopes to get 42 million
COVID-19 vaccines to cover one-fifth of its population through
the global COVAX scheme, said Faisal Shuaib, head of the
country's primary healthcare agency, on Tuesday.
Shuaib said the batch of vaccines would come as part of
Nigeria's plan to inoculate 40% of the population this year,
with another 30% in 2022. By the end of January, 100,000 doses
of the Pfizer-BioNTech PFE.N BNTX.O vaccine are expected to
arrive, he said.
The COVAX scheme was set up to provide vaccines to poorer
countries such as Nigeria, whose 200 million people and poor
infrastructure pose a daunting challenge to medical officials
rolling out the vaccinations as the West African country battles
a second, larger spike in coronavirus cases.
Nigeria, where officials recorded low coronavirus numbers
through much of 2020, had 1,204 new cases on Monday, its highest
ever, as total confirmed cases edged closer to 100,000.
(Graphic: https://tmsnrt.rs/34pvUyi)
Nigeria will first inoculate frontline health workers, first
responders, national leaders, people vulnerable to coronavirus
and the elderly, Shuaib said during a regular COVID-19 briefing
in the capital Abuja.
He also underscored popular resistance to vaccines and said
Nigeria must educate people on their importance.
"We fear what we don't understand," said Shuaib.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
GRAPHIC-COVID-19 global tracker https://tmsnrt.rs/34pvUyi
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.